# Progress Note 06 — Focused Visit (Care-plan review)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Alexander the Great (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-AC002-SYN
- Date: 2026-05-11
- Fictional facility: St. Posthumous Health Center
- Fictional author: Theodora Papadakis-Mensah, MD
- Calendar frame: modern shifted

- Visit type: Focused Visit (Care-plan review)

## Chief complaint

Nine-week review. **S**

## History of present illness

Alexander runs again and marches a full day with his kit; he is short of breath only at the top of long climbs. The scar aches at 2 of 10 after heavy training, and he uses the lidocaine patch three or four nights a week. He has kept to his drinking limits at every banquet in the past three weeks and has had no alcohol on most days. He sees the addiction medicine and behavioral health clinicians every two weeks. He sleeps six to seven hours and says the grief is still there but no longer runs his days. His HIV, hepatitis C and hepatitis B tests from the preventive visit were negative, with immunity to hepatitis B from his childhood vaccines. He is planning the next campaign. **S**

| Element | Detail |
|---|---|
| Spirometry | FVC 4.14 L (83 percent predicted); FEV1 3.46 L (83 percent); ratio 0.84 |
| Chest wall pain | 2 of 10 after heavy training |
| Alcohol | Within his goal for three weeks; PEth 31 ng/mL; AUDIT-C 3 |
| Mood | PHQ-9 5, item 9 scored 0 |
| Screening | HIV, hepatitis C and hepatitis B negative; hepatitis B immune |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Respiratory | Positive | Short of breath only at the top of long climbs |
| Musculoskeletal | Positive | Scar ache 2 of 10 after training |
| Constitutional | Negative | Energy good; no fevers |
| Psychiatric | Negative | Mood steadier; no thoughts of self-harm |

4 systems reviewed. **S**

## Current medications

- Acetaminophen 500 mg oral tablet, one or two tablets up to four times a day as needed for chest wall pain, no more than 2,000 mg in a day while he is drinking heavily **S**
- Thiamine 100 mg oral tablet once daily for three months **S**
- Lidocaine 5% medicated patch, one patch over the painful scar for up to 12 hours in each 24 hours **S**

## Allergies

- No known allergy **S**

## Objective

BP 120/76 mmHg; pulse 66 bpm; respirations 14/min; temperature 36.6 °C; oxygen saturation 99% on room air; weight 71.5 kg; BMI 24.7 kg/m². All vital signs are synthetic.

Forced vital capacity: 4.14 L; FVC percent predicted: 83%; FEV1: 3.46 L; FEV1 percent predicted: 83%; FEV1/FVC ratio: 0.84; PEth (alcohol marker): 31 ng/mL (high); AUDIT-C: 3; PHQ-9: 5; Chest wall pain (0 to 10): 2. All results are synthetic.

## Change since baseline

- Forced vital capacity: 3.92 L (low) at baseline, 4.14 L at this visit **S**
- FVC percent predicted: 78% (low) at baseline, 83% at this visit **S**
- FEV1: 3.29 L (low) at baseline, 3.46 L at this visit **S**
- FEV1 percent predicted: 79% (low) at baseline, 83% at this visit **S**
- FEV1/FVC ratio: 0.84 at baseline, 0.84 at this visit **S**
- PEth (alcohol marker): 236 ng/mL (high) at baseline, 31 ng/mL (high) at this visit **S**
- PHQ-9: 12 at baseline, 5 at this visit **S**
- Chest wall pain (0 to 10): 6 at baseline, 2 at this visit **S**

## Physical examination

| System | Finding |
|---|---|
| General | Well; blood pressure 120/76, pulse 66; weight 71.5 kg |
| Respiratory | Slightly reduced breath sounds at the left base, unchanged; no crackles |
| Musculoskeletal | Minimal tenderness over the left fifth rib; no allodynia |
| Psychiatric | Bright and engaged; no thoughts of suicide |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Localized left fibrothorax** (J94.1). FVC 83 and FEV1 83 percent predicted, at the lower limit of normal, up about 6 percent as pain and splinting eased; the pleural thickening itself is not expected to change. **S**
   - Continue the home exercise program.
   - Spirometry again in a year, or sooner if breathlessness returns.
2. **Chronic post-traumatic chest wall pain** (G89.21). 2 of 10, within his goal. **S**
   - Lidocaine patch as needed.
   - No opioid or sedating medicine.
3. **Alcohol use disorder, mild** (F10.10). PEth 31 ng/mL and AUDIT-C 3: drinking within his goal. **S**
   - Continue the goal; addiction medicine sessions every four weeks from now.
   - Thiamine to finish at three months.
   - PEth in three months.
4. **Bereavement with depressive symptoms** (Z63.4). PHQ-9 5, from 12. Safety reviewed: no thoughts of suicide or self-harm; pistol in the armory off duty; 988 card carried. **S**
   - Behavioral health sessions every four weeks.
   - PHQ-9 in a month; review for prolonged grief disorder only if intense grief continues past the first year.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Chest wall pain score (0 to 10) and examination of the scar and ribs | Every visit | Completed today | 2 of 10; minimal tenderness; no allodynia |
| Imaging | Spirometry (ATS/ERS 2019 quality) | At diagnosis, and two to three months into the exercise program | Completed today | FVC 4.14 L, 83 percent; FEV1 3.46 L, 83 percent; ratio 0.84 |
| Medication safety | Lidocaine patch: effect and skin check | As needed | Completed today | Three or four nights a week; no skin irritation |
| Medication safety | Analgesic safety: acetaminophen limit; no opioids, tramadol, gabapentinoids or benzodiazepines | Every visit | Completed today | No opioid or sedating medicine |
| Self-management | Physical therapy and the breathing and exercise program | Home exercises daily | Completed today | Running and marching again |
| Survey | Drinking since the last visit (self-report against his goal) | Every visit | Completed today | Within his goal for three weeks |
| Laboratory | PEth | At baseline and every four to six weeks while drinking is changing | Completed today | 31 ng/mL |
| Survey | AUDIT-C | At about two to three months | Completed today | 3, answered for the weeks since intake |
| Laboratory | Liver tests (AST, ALT, GGT) | At baseline and four to six weeks later | Up to date | Normal at six weeks |
| Referral | Sessions with the addiction medicine clinician | Every two weeks, then every four | Completed today | Five sessions; every four weeks from now |
| Survey | PHQ-9 (item 9 reviewed) | At intake, then every four to six weeks while symptoms are active (no antidepressant) | Completed today | 5, from 12; item 9 scored 0 |
| Survey | Grief review (prolonged grief disorder not diagnosable before twelve months) | At each mood review | Completed today | Grief present but no longer disabling |
| Referral | Sessions with the behavioral health clinician | Every two weeks, then every four | Completed today | Five sessions; every four weeks from now |
| Survey | Suicide-risk review, lethal means, safety plan and the 988 Suicide & Crisis Lifeline | Every visit | Completed today | No thoughts of suicide or self-harm; pistol in the armory off duty; 988 card carried |
| Medication safety | Thiamine | Daily for three months | Completed today | To finish in four weeks |

## Goal progress

- Find out why the old wound still hurts and why he is breathless, and whether anything remains in the chest. Outcome by 2026-03-23: Post-traumatic intercostal pain and a localized fibrothorax with mild restriction; no retained fragment, fistula or trapped lung; no surgery needed. **S**
- Chest wall pain 3 of 10 or less on exertion, without opioids. Outcome by 2026-05-11: 6 to 2 of 10 on the lidocaine patch, acetaminophen and the exercise program. **S**
- Back to long marches and runs without stopping for breath. In progress; target 2026-08-10. **S**
- No more than four drinks on any day and fourteen in a week, no riding or driving after drinking, and two or more alcohol-free days a week. In progress; target 2026-08-10. **S**
- Sleep seven hours, and room to grieve. In progress; target 2026-08-10. **S**

## Guideline basis

- Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical Statement (2019), American Thoracic Society and European Respiratory Society (Am J Respir Crit Care Med 2019;200(8):e70-e88)
- ERS/ATS technical standard on interpretive strategies for routine lung function tests (2022), European Respiratory Society and American Thoracic Society (Eur Respir J 2022;60(1):2101499)
- British Thoracic Society Guideline for pleural disease (2023), British Thoracic Society (Thorax 2023;78(Suppl 3):s1-s42)
- CDC Clinical Practice Guideline for Prescribing Opioids for Pain - United States, 2022 (2022), Centers for Disease Control and Prevention (MMWR Recomm Rep 2022;71(3):1-95)
- Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions (2018), U.S. Preventive Services Task Force
- VA/DoD Clinical Practice Guideline for the Management of Substance Use Disorders (2021), United States Department of Veterans Affairs and Department of Defense
- CMID: Clinical Monitoring Intelligence Database, depression monograph (2026), Aether Forge
- VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024), United States Department of Veterans Affairs and Department of Defense

## Follow-up

- Primary care in three months with PEth and PHQ-9, or sooner for more breathlessness or chest pain. Pulmonology review in a year with spirometry. Addiction medicine and behavioral health every four weeks. The clinic or 988 at any hour. **S**

